HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$42.00
Day range
$40.55 - $41.61
Year range
$23.14 - $48.89
Market cap
1.98B USD
Avg Volume
378.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 90.38M | 89.37% |
Operating expense | 82.26M | 31.30% |
Net income | -14.24M | 39.65% |
Net profit margin | -15.75 | 68.13% |
Earnings per share | -0.30 | 47.37% |
EBITDA | -6.63M | 70.52% |
Effective tax rate | -2.50% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 284.44M | -7.05% |
Total assets | 667.89M | 2.65% |
Total liabilities | 435.87M | 14.23% |
Total equity | 232.02M | — |
Shares outstanding | 48.00M | — |
Price to book | 8.68 | — |
Return on assets | -4.77% | — |
Return on capital | -5.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.24M | 39.65% |
Cash from operations | 3.98M | 121.86% |
Cash from investing | -18.04M | 90.13% |
Cash from financing | 3.86M | -98.13% |
Net change in cash | -10.10M | -273.23% |
Free cash flow | -11.28M | 40.17% |
About
Founded
2018
Headquarters
Website
Employees
311
